Harmony Biosciences Holdings (HRMY) financials · P/E 12, rev $868.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Harmony Biosciences Holdings (HRMY) P/E 12, rev $868.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $868.5M | $714.7M |
| Cost of Revenue | $198.3M | $156.8M |
| Gross Profit | $670.1M | $557.9M |
| Operating Income | $208.5M | $190.8M |
| Net Income | $158.7M | $145.5M |
| EPS (Diluted) | $2.71 | $2.51 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.27B | $999.2M |
| Current Assets | $907.0M | $579.3M |
| Cash & Equivalents | $752.5M | $453.0M |
| Inventory | $5.36M | $7.20M |
| PP&E | N/A | $1.26M |
| Total Liabilities | $401.4M | $340.0M |
| Current Liabilities | $252.1M | $175.1M |
| Short-term Debt | $20.0M | $16.3M |
| Long-term Debt | $143.7M | $163.0M |
| Total Debt | $163.7M† | $179.3M† |
| Shareholders' Equity | $870.2M | $659.2M |
| Retained Earnings | $160.9M | $2.22M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $348.2M | $219.8M |
| CapEx | $310.0K | $1.15M |
| Investing Cash Flow | -$39.6M | -$67.5M |
| Financing Cash Flow | -$9.05M | -$11.0M |
| Net Change in Cash | $299.5M | $141.3M |
| Free Cash Flow | $347.9M | $218.7M |
FAQ
What is HRMY P/E and revenue?
Harmony Biosciences Holdings (HRMY) P/E 12, rev $868.5M.
What is HRMY revenue?
Harmony Biosciences Holdings last cached revenue is $868.5M (FY2025).
Is HRMY profitable?
Harmony Biosciences Holdings last cached net income is $158.7M (FY2025).
What are HRMY total assets?
Harmony Biosciences Holdings last cached total assets are $1.27B (FY2025).
What is HRMY free cash flow?
Harmony Biosciences Holdings last cached free cash flow is $347.9M (FY2025).
Not investment advice. Cached statements, not a live tape.